Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2023. Start Trial.
Date Value
September 30, 2026 49.64M
June 30, 2026 47.95M
March 31, 2026 47.57M
December 31, 2025 44.93M
September 30, 2025 44.72M
June 30, 2025 33.59M
March 31, 2025 33.42M
December 31, 2024 33.42M
Date Value
September 30, 2024 33.38M
June 30, 2024 33.38M
March 31, 2024 33.38M
December 31, 2023 33.38M
September 30, 2023 33.38M
June 30, 2023 33.38M
March 31, 2023 33.38M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Ligand Pharmaceuticals, Inc. 20.00M
Xeris Biopharma Holdings, Inc. 182.57M
ANI Pharmaceuticals, Inc. 22.90M
Corcept Therapeutics, Inc. 109.36M
Veru, Inc. 17.05M